Recruiting Real-World Study on CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent Treatment in HR+/HER2- MBC. NCT06033287 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more Locations Hunan Cancer Hospital — Changsha, Hunan, China View Trial Details
Recruiting Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study NCT06805812 Conditions Abemaciclib, Breast Adenocarcinoma, Breast Cancer, +46 more Locations Centro di Riferimento Oncologico IRCCS — Aviano, Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili — Brescia, Italy Humanitas Istituto Clinico Catanese — Catania, Italy ASST Lariana - Ospedale Sant'Anna — Como, Italy View all 24 locations View more locations Show fewer locations Loading locations... View Trial Details
Enrolling by Invitation Impact of an Artificial Intelligence-Based Management Model on Psychological and Behavioral Outcomes in Breast Cancer Patients Undergoing Home CDK4/6 Inhibitor Therapy NCT07409298 Conditions Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more Locations Tianjin Medical University Cancer Institute & Hospital — Tianjin, China View Trial Details
